Cystic fibrosis, pathophysiological and clinical aspects.

作者: H. J. Neijens , M. Sinaasappel , R. de Groot , J. C. de Jongste , S. E. Overbeek

DOI: 10.1007/BF01957271

关键词:

摘要: Cystic fibrosis is a lethal, hereditary, until recently little understood disease, which leads to progressive functional disturbances in various organs, including the lungs, liver and pancreas. Knowledge of genetic cellular abnormalities rapidly progressing, but therapy still symptomatic based on insufficiently controlled short-term studies. At present therapeutic approach aims combat respiratory infections by optimal antibiotic therapy, combined with techniques promote sputum evacuation. Additional measures attempt optimise both nutritional state physical condition. Median survival has imporved from approximately 1 year about 25 years during past 3 decades. This article summarises information disease mechanisms treatment.

参考文章(116)
B E Scully, S Davidson, M Nakatomi, H C Neu, C Ores, Ciprofloxacin therapy in cystic fibrosis The American Journal of Medicine. ,vol. 82, pp. 196- 201 ,(1987)
Sabine Maguire, Edward Tempany, Patricia Moriarty, Muiris FitzGerald, Unusual clustering of allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Pediatrics. ,vol. 82, pp. 835- 839 ,(1988)
Di Sant'agnese Pa, Perera Ga, Shea E, Darling Rc, ABNORMAL ELECTROLYTE COMPOSITION OF SWEAT IN CYSTIC FIBROSIS OF THE PANCREAS: Clinical Significance and Relationship to the Disease Pediatrics. ,vol. 12, pp. 549- 563 ,(1953)
Hinda Kopelman, Mary Corey, Kevin Gaskin, Peter Durie, Zvi Weizman, Gordon Forstner, Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas Gastroenterology. ,vol. 95, pp. 349- 355 ,(1988) , 10.1016/0016-5085(88)90490-8
Jerome Liebman, Herbert Ruttenberg, Arthur Moss, Ernest Cotton, Russell Lucas, Amnon Rosenthal, Airline Travel for Children With Chronic Pulmonary Disease Pediatrics. ,vol. 57, pp. 408- 410 ,(1976)
Gerd Döring, Walter Goldstein, Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. The American review of respiratory disease. ,vol. 134, pp. 49- 56 ,(1986) , 10.1164/ARRD.1986.134.1.49
M Pollack, S E Anderson, Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages. Infection and Immunity. ,vol. 19, pp. 1092- 1096 ,(1978) , 10.1128/IAI.19.3.1092-1096.1978
H. J. Neijens, J. M. Bogaard, H. Stam, F. G. A. Versteegh, J. W. Raatgever, K. F. Kerrebijn, Relationship between airway obstruction, desaturation during exercise and nocturnal hypoxaemia in cystic fibrosis patients. European Respiratory Journal. ,vol. 3, pp. 68- 73 ,(1990)
Allan Weber, Robin L. Davis, Arnold L. Smith, Paul M. Mendelman, Bonnie Ramsey, Jack Levy, Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum The American review of respiratory disease. ,vol. 132, pp. 761- 765 ,(1985) , 10.1164/ARRD.1985.132.4.761